Details of the Drug
General Information of Drug (ID: DME0TZU)
| Drug Name |
2,7-diaminoanthraquinone
|
||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Synonyms |
2,7-Diaminoanthraquinone; 2,7-Diaminoanthrachinon; BRN 2809381; 605-44-7; 2,7-Diaminoanthrachinon [Czech]; 2,7-diaminoanthracene-9,10-dione; 9,10-Anthracenedione, 2,7-diamino- (9CI); ANTHRAQUINONE, 2,7-DIAMINO-; 9,10-Anthracenedione, 2,7-diamino-; AC1L1Y5O; SCHEMBL3135129; CHEMBL454957; CTK5B1667; DTXSID20209235; KJNHYKBXQOSFJR-UHFFFAOYSA-N; ZINC31483469; 9,10-Anthracenedione,2,7-diamino-; AKOS030561506
|
||||||||||||||||||||||
| Indication |
|
||||||||||||||||||||||
| Drug Type |
Small molecular drug
|
||||||||||||||||||||||
| Structure |
![]() |
||||||||||||||||||||||
| 3D MOL | 2D MOL | ||||||||||||||||||||||
| #Ro5 Violations (Lipinski): 0 | Molecular Weight (mw) | 238.24 | |||||||||||||||||||||
| Logarithm of the Partition Coefficient (xlogp) | 1.5 | ||||||||||||||||||||||
| Rotatable Bond Count (rotbonds) | 0 | ||||||||||||||||||||||
| Hydrogen Bond Donor Count (hbonddonor) | 2 | ||||||||||||||||||||||
| Hydrogen Bond Acceptor Count (hbondacc) | 4 | ||||||||||||||||||||||
| Chemical Identifiers |
|
||||||||||||||||||||||
| Cross-matching ID | |||||||||||||||||||||||
Molecular Interaction Atlas of This Drug
![]() Drug Therapeutic Target (DTT) |
|
||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Molecular Interaction Atlas (MIA) | |||||||||||||||||||||||||||


